CPHI [CHINA PHARMAS,] 10-K/A: o x o x x o x Large

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K/A, Date: 2009-06-24
Original SEC Filing: Click here


Webplus: CPHI/20090624/10-K.A/1/000.htm SEC Original: cph10ka123108.htm
o x o x x o x Large accelerated filer o Accelerated filer o Non-accelerated filer o Smaller Reportingmpany x o x The issuer’s revenue for the fiscal year ended December 31, 2008 was $50,968,660. of March 12, 2008, there were 42,278,938 shares ofmmon Stock issued and outstanding.




Webplus: CPHI/20090624/10-K.A/2_EX-10.7/000.htm SEC Original: cph10kaex107123108.htm
January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5ys of the start of the quarter. If youree to the terms andnditions statedove, please sign andte this letter below. Chairman of the Board cph10kaex107123108.htm 2 EX-10.7




Webplus: CPHI/20090624/10-K.A/3_EX-10.8/000.htm SEC Original: cph10kaex108123108.htm
January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5ys of the start of the quarter. If youree to the terms andnditions statedove, please sign andte this letter below. Chairman of the Board cph10kaex108123108.htm 3 EX-10.8




Webplus: CPHI/20090624/10-K.A/4_EX-31.1/000.htm SEC Original: cph10kaex311123108.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not




Webplus: CPHI/20090624/10-K.A/5_EX-31.2/000.htm SEC Original: cph10kaex312123108.htm
CERTIFICATION OF CHIEFFINANCIAL OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Frank Waung, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading




Webplus: CPHI/20090624/10-K.A/6_EX-32.1/000.htm SEC Original: cph10kaex321123108.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 Zhilin Li Chief Executive Officer cph10kaex321123108.htm 6 EX-32.1




Webplus: CPHI/20090624/10-K.A/7_EX-32.2/000.htm SEC Original: cph10kaex322123108.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 Frank Waung ChiefFinancial Officer cph10kaex322123108.htm 7 EX-32.2



Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K/A, Date: 2009-06-24CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216

Home Page Forums

By | 2016-02-08T00:32:50+00:00 June 24th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar